Publishing research using ab55335? Please let us know so that we can cite the reference in this datasheet.

ab55335 has been referenced in 1 publication.

  • Herold CI  et al. Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing. Clin Cancer Res 17:6061-70 (2011). IHC-P ; Human . PubMed: 21810917

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"